136 related articles for article (PubMed ID: 38212190)
1. Weekly Paclitaxel for Pregnancy Associated Breast Cancer.
Girardelli S; Bonomo B; Papale M; di Loreto E; Grossi E; Scarfone G; Rabaiotti E; Valsecchi L; Mangili G; Candiani M; Peccatori F
Clin Breast Cancer; 2024 Apr; 24(3):199-203. PubMed ID: 38212190
[TBL] [Abstract][Full Text] [Related]
2. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients.
de Haan J; Verheecke M; Van Calsteren K; Van Calster B; Shmakov RG; Mhallem Gziri M; Halaska MJ; Fruscio R; Lok CAR; Boere IA; Zola P; Ottevanger PB; de Groot CJM; Peccatori FA; Dahl Steffensen K; Cardonick EH; Polushkina E; Rob L; Ceppi L; Sukhikh GT; Han SN; Amant F;
Lancet Oncol; 2018 Mar; 19(3):337-346. PubMed ID: 29395867
[TBL] [Abstract][Full Text] [Related]
3. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome.
Bond DM; Middleton P; Levett KM; van der Ham DP; Crowther CA; Buchanan SL; Morris J
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004735. PubMed ID: 28257562
[TBL] [Abstract][Full Text] [Related]
4. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
Goble S; Bear HD
Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
[TBL] [Abstract][Full Text] [Related]
5. Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis.
Sella T; Exman P; Ren S; Freret TS; Economy KE; Chen WY; Parsons HA; Lin NU; Moy B; Tung NM; Partridge AH; Tayob N; Mayer EL
Breast Cancer Res Treat; 2022 Aug; 194(3):597-606. PubMed ID: 35715538
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. [Retrospective analysis of diagnosis and treatment of breast cancer in pregnancy].
Wang FW; Fu SM; Jin YC; Gong XH; Cheng HD; Wu KJ
Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):114-118. PubMed ID: 29397624
[No Abstract] [Full Text] [Related]
8. Impact of chemotherapy during pregnancy on fetal growth.
Maggen C; Wolters VERA; Van Calsteren K; Cardonick E; Laenen A; Heimovaara JH; Mhallem Gziri M; Fruscio R; Duvekot JJ; Painter RC; Masturzo B; Shmakov RG; Halaska M; Berveiller P; Verheecke M; de Haan J; Gordijn SJ; Amant F;
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10314-10323. PubMed ID: 36202393
[TBL] [Abstract][Full Text] [Related]
9. Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer.
Zaheed M; Wilcken N; Willson ML; O'Connell DL; Goodwin A
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012873. PubMed ID: 30776132
[TBL] [Abstract][Full Text] [Related]
10. Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study.
Maggen C; Dierickx D; Lugtenburg P; Laenen A; Cardonick E; Shmakov RG; Bellido M; Cabrera-Garcia A; Gziri MM; Halaska MJ; Ottevanger PB; Van Calsteren K; O'Laughlin A; Polushkina E; Van Dam L; Avivi I; Vandenberghe P; Woei-A-Jin FJSH; Amant F;
Lancet Haematol; 2019 Nov; 6(11):e551-e561. PubMed ID: 31564649
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity.
Thinkhamrop J; Hofmeyr GJ; Adetoro O; Lumbiganon P; Ota E
Cochrane Database Syst Rev; 2015 Jan; 1():CD002250. PubMed ID: 25621770
[TBL] [Abstract][Full Text] [Related]
12. Obstetric and neonatal outcomes following taxane use during pregnancy: a systematic review.
Aranda-Gutierrez A; Ferrigno Guajardo AS; Vaca-Cartagena BF; Gonzalez-Sanchez DG; Ramirez-Cisneros A; Becerril-Gaitan A; Azim HA; Villarreal-Garza C
BMC Cancer; 2024 Jan; 24(1):9. PubMed ID: 38166767
[TBL] [Abstract][Full Text] [Related]
13. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity.
Thinkhamrop J; Hofmeyr GJ; Adetoro O; Lumbiganon P; Ota E
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD002250. PubMed ID: 26092137
[TBL] [Abstract][Full Text] [Related]
15. The fetal outcomes after neoadjuvant platinum and paclitaxel chemotherapy during pregnancy: analysis of three cases and review of the literature.
Wang M; Yin Z; Miao J; Wu Y
Arch Gynecol Obstet; 2022 Jan; 305(1):49-54. PubMed ID: 34115181
[TBL] [Abstract][Full Text] [Related]
16. Weekly Paclitaxel Administered During a Twin Pregnancy for Recurrent Breast Cancer: Case Report and Review of the Literature.
Girardelli S; Rabaiotti E; Mauro F; Gentilini O; Zucchinelli P; Cioffi R; Valsecchi L; Mangili G; Peccatori FA; Candiani M
J Adolesc Young Adult Oncol; 2022 Dec; 11(6):632-636. PubMed ID: 35180353
[TBL] [Abstract][Full Text] [Related]
17. Optimal timing of cervical cerclage removal following preterm premature rupture of membranes; a retrospective analysis.
Suff N; Kunitsyna M; Shennan A; Chandiramani M
Eur J Obstet Gynecol Reprod Biol; 2021 Apr; 259():75-80. PubMed ID: 33601316
[TBL] [Abstract][Full Text] [Related]
18. Weekly taxane-anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial.
Tan QW; Luo T; Zheng H; Tian TL; He P; Chen J; Zeng HL; Lv Q
Chin J Cancer; 2017 Mar; 36(1):27. PubMed ID: 28270181
[TBL] [Abstract][Full Text] [Related]
19. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).
Middleton P; Shepherd E; Flenady V; McBain RD; Crowther CA
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD005302. PubMed ID: 28050900
[TBL] [Abstract][Full Text] [Related]
20. Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study.
Frasci G; Comella P; D'Aiuto G; Budillon A; Barbarulo D; Thomas R; Capasso I; Casaretti R; Daponte A; Caponigro F; Gravina A; Maiorino L; Caratenà G; Gentile A; Comella G
Breast Cancer Res Treat; 1998 May; 49(1):13-26. PubMed ID: 9694607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
